Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Thumbnail

White House indefinitely postpones Trump's speech on lowering drug prices

President Donald Trump has postponed this week’s speech on battling rising prescription drug costs, according to the White House. No future date, time or location has been announced for the speech, previously scheduled for Thursday, April 26.

Thumbnail

Primary care may be skipped under high-deductible ACA plans

Higher deductible bronze-level plans were more popular on the Affordable Care Act (ACA) exchanges in 2018, but customers may not be aware that moving toward this coverage will leave them paying out of pocket for primary care until they hit their deductible—leading some to avoid primary care altogether due to the costs.

Thumbnail

Democrat senator’s report calls tax law ‘bonanza’ for healthcare

Some of the largest healthcare companies, including for-profit hospital chains, insurers and pharmaceuticals, will pay a combined $10 billion less in taxes for 2018 thanks to the corporate tax cuts passed by Republicans and signed into law by President Donald Trump, according to a report published by Sen. Ron Wyden, D-Oregon.

Thumbnail

Healthcare groups want MIPS changes on measures, reporting period

The Medical Group Management Association (MGMA), American Medical Association (AMA) and the American College of Physicians (ACP) are asking for changes to the Merit-based Incentive Payment System (MIPS), with a wide group of stakeholders wanting the quality reporting period reduced to 90 days and ACP releasing a study determining many MIPS measures aren’t valid.

Thumbnail

DOJ will examine Cigna-Express Scripts deal

The U.S. Department of Justice (DOJ) will review Cigna’s $67 billion proposal to acquire Express Scripts, the results of which are likely to have major ramifications on other vertical integrations being explored across healthcare.

Thumbnail

Procter & Gamble buying Merck’s health brands for $4.2B

Procter & Gamble has announced it will acquire the consumer health business of Germany-based Merck in a $4.2 billion deal, adding more over-the-counter medications to P&G’s existing product offerings.

Thumbnail

Dem senators introduce plan for ‘public option on steroids’

Millions more Americans could pick Medicare as their health insurer under a bill introduced by Sens. Chris Murphy, D-Connecticut, and Jeff Merkley, D-Oregon, by making it a public insurance option on the Affordable Care Act (ACA) exchanges and for employers.

Thumbnail

Piedmont, Georgia BCBS settle contract dispute after governor gets involved

One of the largest health systems in Atlanta and one of Georgia’s biggest insurers have settled a months-long dispute over a new contract after Georgia Gov. Nathan Deal threatened to take executive action to push the sides to negotiate.

Around the web

The FTC alleges that pharmacy benefit managers have set up a system where they get rich, while patients are forced to pay rising insulin costs. The agency also called out drug manufacturers such as Eli Lilly, Sanofi and Novo Nordisk, saying their own actions have raised serious concerns.

In the post-COVID era, wages for permanent RNs are rising, and wages for travelers are decreasing. A new report tracked these trends and more. 

Two medical device companies have announced a transaction that could shake up the U.S. electrophysiology market. 

Trimed Popup
Trimed Popup